Patents by Inventor Oliver Pohl

Oliver Pohl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
    Publication number: 20150164859
    Abstract: The present invention relates to solid oral formulations comprising a compound of formula (3Z,5S)-5-(hydroxymethyl)-1-[(2?-methyl-1,1?-biphenyl-4-yl)carbonyl]pyrrolidin-3-one-O-methyloxime, and/or an active metabolite thereof, and the use of said formulations in the treatment and/or prevention of preterm labor, premature birth, dysmenorrhea and embryo implantation failure due to uterine contractions. The present invention is furthermore related to processes for their preparation.
    Type: Application
    Filed: December 16, 2014
    Publication date: June 18, 2015
    Inventors: Andre CHOLLET, Oliver POHL
  • Steroid Sulfatase Inhibitor Regimen for the Treatment of Endometriosis
    Publication number: 20150065470
    Abstract: The present invention is related to a dosage regimen of a steroid sulfatase inhibitor, E2MATE, for use in the prevention or treatment of endometriosis. The present invention further relates to a method for preventing or treating endometriosis.
    Type: Application
    Filed: April 4, 2013
    Publication date: March 5, 2015
    Applicant: PregLem SA
    Inventors: Ernest Loumaye, Oliver Pohl, Jean-Pierre Gotteland